Priveterra Acquisition Corp II(PMGMU)股吧_Priveterra Acquisition Corp II怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
310	0	Current report, items 3.01 and 9.01	Priveterra Acqui资讯	05-04 04:04
297	0	Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KS	Priveterra Acqui资讯	04-03 05:32
384	0	[Amend] Statement of acquisition of beneficial ownership by individuals	Priveterra Acqui资讯	02-15 03:34
381	0	[Amend] Statement of acquisition of beneficial ownership by individuals	Priveterra Acqui资讯	02-15 02:20
391	0	Current report, items 3.01, 5.03, 5.07, and 9.01	Priveterra Acqui资讯	01-12 06:20
343	0	Other definitive proxy statements	Priveterra Acqui资讯	12-20 06:53
341	0	Other preliminary proxy statements	Priveterra Acqui资讯	12-08 05:26
288	0	Quarterly report [Sections 13 or 15(d)]	Priveterra Acqui资讯	11-20 07:53
240	0	Notification of inability to timely file Form 10-Q or 10-QSB	Priveterra Acqui资讯	11-15 09:53
365	0	[Amend] Statement of acquisition of beneficial ownership by individuals	Priveterra Acqui资讯	09-09 05:19
351	0	Statement of acquisition of beneficial ownership by individuals	Priveterra Acqui资讯	08-24 05:34
374	0	Quarterly report [Sections 13 or 15(d)]	Priveterra Acqui资讯	08-22 05:34
364	0	Current report, item 8.01	Priveterra Acqui资讯	08-21 08:18
428	0	Notification of inability to timely file Form 10-Q or 10-QSB	Priveterra Acqui资讯	08-16 04:40
331	0	Current report, items 1.01, 2.03, 5.03, 8.01, and 9.01	Priveterra Acqui资讯	07-22 04:12
259	0	Certification by an exchange approving securities for listing	AEON Biopharma I资讯	07-22 03:46
245	0	Notification of the removal from listing and registration of matured, redeemed	AEON Biopharma I资讯	07-22 02:19
251	0	Registration of securities [Section 12(b)]	AEON Biopharma I资讯	07-22 01:52
245	0	Quarterly report [Sections 13 or 15(d)]	AEON Biopharma I资讯	07-22 12:02
223	0	[Amend] Statement of acquisition of beneficial ownership by individuals	AEON Biopharma I资讯	07-20 11:41
204	0	Registration adding securities to prior Form S-4 registration [Rule 462(b)]	AEON Biopharma I资讯	07-19 05:32
202	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	07-18 06:00
196	0	Current report, items 3.01, 7.01, and 9.01	AEON Biopharma I资讯	07-18 05:51
190	0	Initial statement of beneficial ownership of securities	Priveterra Acqui资讯	07-14 02:54
177	0	Initial statement of beneficial ownership of securities	Priveterra Acqui资讯	07-14 02:54
192	0	Initial statement of beneficial ownership of securities	Priveterra Acqui资讯	07-14 02:54
181	0	Initial statement of beneficial ownership of securities	Priveterra Acqui资讯	07-14 02:54
175	0	Current report, items 5.03, 5.07, and 9.01	Priveterra Acqui资讯	07-13 05:24
161	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	07-12 06:12
181	0	Current report, items 3.01, 7.01, and 9.01	AEON Biopharma I资讯	07-12 06:12
189	0	Current report, item 8.01	Priveterra Acqui资讯	07-11 02:43
156	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Priveterra Acqui资讯	07-11 02:42
140	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	07-06 07:41
137	0	Current report, items 5.02, 5.07, and 8.01	AEON Biopharma I资讯	07-06 07:41
146	0	Current report, items 5.02 and 8.01	Priveterra Acqui资讯	07-06 07:08
161	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Priveterra Acqui资讯	07-06 07:07
141	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	06-30 09:12
126	0	Current report, items 7.01, 8.01, and 9.01	AEON Biopharma I资讯	06-30 09:11
125	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-30 09:11
139	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	06-30 07:50
141	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-30 07:36
142	0	Current report, items 1.01, 3.02, 8.01, and 9.01	AEON Biopharma I资讯	06-30 07:36
120	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-29 10:48
118	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-29 10:23
119	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-27 04:38
111	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-27 04:20
161	0	Other definitive proxy statements	Priveterra Acqui资讯	06-23 08:45
158	0	Current report, items 1.02, 3.01, 8.01, and 9.01	Priveterra Acqui资讯	06-23 05:52
117	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-22 04:59
143	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-22 04:19
164	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-16 05:53
158	0	Current report, items 3.01, 8.01, and 9.01	AEON Biopharma I资讯	06-16 05:03
136	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-14 05:30
145	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-14 05:02
163	0	[Amend] Statement of acquisition of beneficial ownership by individuals	AEON Biopharma I资讯	06-13 05:51
155	0	Other preliminary proxy statements	Priveterra Acqui资讯	06-13 05:39
135	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-09 07:51
133	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-09 07:51
149	0	Current report, items 8.01 and 9.01	AEON Biopharma I资讯	06-06 07:22
149	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AEON Biopharma I资讯	06-06 06:09
210	0	Current report, items 7.01 and 9.01	AEON Biopharma I资讯	05-24 07:12
213	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	05-24 07:09
215	0	Quarterly report [Sections 13 or 15(d)]	AEON Biopharma I资讯	05-18 07:54
193	0	Quarterly report [Sections 13 or 15(d)]	Priveterra Acqui资讯	05-16 09:51
234	0	Notification of inability to timely file Form 10-Q or 10-QSB	AEON Biopharma I资讯	05-16 04:37
235	0	Prospectus [Rule 424(b)(3)]	AEON Biopharma I资讯	05-13 03:21
231	0	Definitive proxy statement relating to merger or acquisition	AEON Biopharma I资讯	05-13 02:55
232	0	Notice of Effectiveness	AEON Biopharma I资讯	05-12 12:00
230	0	[Amend] Registration of securities, business combinations	AEON Biopharma I资讯	05-10 02:22
280	0	[Amend] Registration of securities, business combinations	AEON Biopharma I资讯	05-01 06:43
248	0	Current report, items 1.01 and 9.01	AEON Biopharma I资讯	05-01 06:42
258	0	Prospectuses and communications, business combinations	AEON Biopharma I资讯	05-01 06:42
219	0	Statement of acquisition of beneficial ownership by individuals	Priveterra Acqui资讯	04-12 04:14
221	0	[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]	AEON Biopharma I资讯	04-11 05:59
290	0	Current report, item 4.02	AEON Biopharma I资讯	04-06 08:19
248	0	[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]	AEON Biopharma I资讯	04-06 06:21
263	0	Statement of changes in beneficial ownership of securities	AEON Biopharma I资讯	04-01 06:29
254	0	Initial statement of beneficial ownership of securities	AEON Biopharma I资讯	04-01 05:36
410	0	Annual report [Section 13 and 15(d), not S-K Item 405]	Priveterra Acqui资讯	03-30 06:14
266	0	Statement of acquisition of beneficial ownership by individuals	AEON Biopharma I资讯	03-11 05:37

emytylist